Data platform unifies blood cancer ‘omics’ and clinical data to accelerate discovery
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jun-2026 09:16 ET (22-Jun-2026 13:16 GMT/UTC)
Take a first look at the American Society of Hematology HematOmics Program (ASHOP) platform & its promise to move hematological malignancy research forward.
Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to a study published in Nature Communications Medicine. The strategy extended survival in preclinical models of glioblastoma, the most aggressive form of brain cancer.
The diabetes drug, metformin, may mimic key benefits of exercise in prostate cancer patients, raising a molecule linked to weight and energy control even without activity. The finding suggests a new way to support metabolic health during hormone therapy, when patients often cannot exercise.
A population-based study in Japan published by Wiley online in CANCER has revealed a gradual increase in the rates of therapy-related acute myeloid leukemia in recent years, especially after breast cancer treatment.
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths – around 1.8 million lives lost each year. One of the main reasons is late diagnosis: in its early stages, the disease appears as extremely small nodules that are difficult to distinguish from healthy tissue, even for experienced radiologists. Researchers are now exploring how artificial intelligence (AI) could help solve this challenge by giving doctors a more reliable way to analyse complex medical images.